vs
Progyny, Inc.（PGNY）とGIBRALTAR INDUSTRIES, INC.（ROCK）の財務データ比較。上の社名をクリックして会社を切り替えられます
Progyny, Inc.の直近四半期売上が大きい（$318.4M vs $225.0M、GIBRALTAR INDUSTRIES, INC.の約1.4倍）。GIBRALTAR INDUSTRIES, INC.の前年同期比売上増加率が高い（24.9% vs 6.7%）。Progyny, Inc.の直近四半期フリーキャッシュフローが多い（$48.6M vs $26.2M）。過去8四半期でProgyny, Inc.の売上複合成長率が高い（7.0% vs -12.3%）
Progyny, Inc.は米国を中心に事業を展開する有力な不妊治療・家族形成支援福利厚生サービスプロバイダーです。企業顧客と提携し、体外受精、妊孕性温存、養子縁組支援、代理出産サポートなどの福利厚生を提供し、多様な業種の従業員にサービスを届けています。
ジブラルタル・インダストリーズ社は、特殊建築資材、インフラ関連製品、再生可能エネルギー向け製品の製造・販売を行う有力企業です。換気システム、屋根用付属品、太陽光発電設置架台、造園用品などを取り扱い、主に北米の住宅・商業建設、クリーンエネルギー市場向けにサービスを提供しています。
PGNY vs ROCK — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $318.4M | $225.0M |
| 純利益 | $12.5M | — |
| 粗利率 | 24.1% | 25.3% |
| 営業利益率 | 4.8% | 7.9% |
| 純利益率 | 3.9% | — |
| 売上前年比 | 6.7% | 24.9% |
| 純利益前年比 | 18.5% | — |
| EPS（希薄化後） | $0.14 | — |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $318.4M | $225.0M | ||
| Q3 25 | $313.3M | $310.9M | ||
| Q2 25 | $332.9M | $309.5M | ||
| Q1 25 | $324.0M | $290.0M | ||
| Q4 24 | $298.4M | $180.1M | ||
| Q3 24 | $286.6M | $277.1M | ||
| Q2 24 | $304.1M | $273.6M | ||
| Q1 24 | $278.1M | $292.5M |
| Q4 25 | $12.5M | — | ||
| Q3 25 | $13.9M | $-89.1M | ||
| Q2 25 | $17.1M | $26.0M | ||
| Q1 25 | $15.1M | $21.1M | ||
| Q4 24 | $10.5M | — | ||
| Q3 24 | $10.4M | $34.0M | ||
| Q2 24 | $16.5M | $32.2M | ||
| Q1 24 | $16.9M | $24.9M |
| Q4 25 | 24.1% | 25.3% | ||
| Q3 25 | 23.2% | 26.6% | ||
| Q2 25 | 23.7% | 28.4% | ||
| Q1 25 | 23.4% | 26.8% | ||
| Q4 24 | 21.3% | 29.0% | ||
| Q3 24 | 20.7% | 29.4% | ||
| Q2 24 | 22.5% | 30.5% | ||
| Q1 24 | 22.4% | 28.9% |
| Q4 25 | 4.8% | 7.9% | ||
| Q3 25 | 6.9% | 12.8% | ||
| Q2 25 | 7.3% | 12.8% | ||
| Q1 25 | 7.5% | 8.8% | ||
| Q4 24 | 5.3% | 13.3% | ||
| Q3 24 | 4.3% | 15.6% | ||
| Q2 24 | 6.8% | 14.9% | ||
| Q1 24 | 6.7% | 10.8% |
| Q4 25 | 3.9% | — | ||
| Q3 25 | 4.4% | -28.6% | ||
| Q2 25 | 5.1% | 8.4% | ||
| Q1 25 | 4.6% | 7.3% | ||
| Q4 24 | 3.5% | — | ||
| Q3 24 | 3.6% | 12.3% | ||
| Q2 24 | 5.4% | 11.8% | ||
| Q1 24 | 6.1% | 8.5% |
| Q4 25 | $0.14 | — | ||
| Q3 25 | $0.15 | $-2.98 | ||
| Q2 25 | $0.19 | $0.87 | ||
| Q1 25 | $0.17 | — | ||
| Q4 24 | $0.12 | — | ||
| Q3 24 | $0.11 | $1.11 | ||
| Q2 24 | $0.17 | $1.05 | ||
| Q1 24 | $0.17 | — |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $112.2M | $115.7M |
| 総負債低いほど良い | — | $0 |
| 株主資本純資産 | $516.0M | $950.4M |
| 総資産 | $742.4M | $1.4B |
| 負債/資本比率低いほどレバレッジが低い | — | 0.00× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $112.2M | $115.7M | ||
| Q3 25 | $134.0M | $89.4M | ||
| Q2 25 | $132.5M | $43.3M | ||
| Q1 25 | $109.2M | $25.1M | ||
| Q4 24 | $162.3M | $269.5M | ||
| Q3 24 | $91.5M | $228.9M | ||
| Q2 24 | $95.0M | $179.1M | ||
| Q1 24 | $115.0M | $146.7M |
| Q4 25 | — | $0 | ||
| Q3 25 | — | $0 | ||
| Q2 25 | — | $0 | ||
| Q1 25 | — | $0 | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $0 | ||
| Q1 24 | — | $0 |
| Q4 25 | $516.0M | $950.4M | ||
| Q3 25 | $560.0M | $951.8M | ||
| Q2 25 | $515.0M | $1.0B | ||
| Q1 25 | $467.2M | $1.0B | ||
| Q4 24 | $422.1M | $1.0B | ||
| Q3 24 | $434.9M | $1.0B | ||
| Q2 24 | $456.2M | $975.7M | ||
| Q1 24 | $571.6M | $940.2M |
| Q4 25 | $742.4M | $1.4B | ||
| Q3 25 | $795.2M | $1.4B | ||
| Q2 25 | $761.0M | $1.5B | ||
| Q1 25 | $730.3M | $1.4B | ||
| Q4 24 | $607.1M | $1.4B | ||
| Q3 24 | $660.0M | $1.4B | ||
| Q2 24 | $698.6M | $1.4B | ||
| Q1 24 | $794.3M | $1.3B |
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | 0.00× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $54.2M | $35.5M |
| フリーキャッシュフロー営業CF - 設備投資 | $48.6M | $26.2M |
| FCFマージンFCF / 売上 | 15.3% | 11.7% |
| 設備投資強度設備投資 / 売上 | 1.8% | 4.1% |
| キャッシュ転換率営業CF / 純利益 | 4.34× | — |
| 直近12ヶ月FCF直近4四半期 | $191.8M | $120.6M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $54.2M | $35.5M | ||
| Q3 25 | $50.7M | $73.0M | ||
| Q2 25 | $55.5M | $44.9M | ||
| Q1 25 | $49.8M | $13.7M | ||
| Q4 24 | $52.2M | $19.9M | ||
| Q3 24 | $44.5M | $64.7M | ||
| Q2 24 | $56.7M | $36.5M | ||
| Q1 24 | $25.7M | $53.2M |
| Q4 25 | $48.6M | $26.2M | ||
| Q3 25 | $46.0M | $64.8M | ||
| Q2 25 | $50.2M | $27.3M | ||
| Q1 25 | $47.0M | $2.3M | ||
| Q4 24 | $50.3M | $14.1M | ||
| Q3 24 | $42.7M | $60.5M | ||
| Q2 24 | $55.8M | $33.5M | ||
| Q1 24 | $24.9M | $48.8M |
| Q4 25 | 15.3% | 11.7% | ||
| Q3 25 | 14.7% | 20.8% | ||
| Q2 25 | 15.1% | 8.8% | ||
| Q1 25 | 14.5% | 0.8% | ||
| Q4 24 | 16.8% | 7.8% | ||
| Q3 24 | 14.9% | 21.8% | ||
| Q2 24 | 18.4% | 12.2% | ||
| Q1 24 | 8.9% | 16.7% |
| Q4 25 | 1.8% | 4.1% | ||
| Q3 25 | 1.5% | 2.6% | ||
| Q2 25 | 1.6% | 5.7% | ||
| Q1 25 | 0.9% | 3.9% | ||
| Q4 24 | 0.6% | 3.3% | ||
| Q3 24 | 0.6% | 1.5% | ||
| Q2 24 | 0.3% | 1.1% | ||
| Q1 24 | 0.3% | 1.5% |
| Q4 25 | 4.34× | — | ||
| Q3 25 | 3.65× | — | ||
| Q2 25 | 3.24× | 1.73× | ||
| Q1 25 | 3.31× | 0.65× | ||
| Q4 24 | 4.95× | — | ||
| Q3 24 | 4.27× | 1.90× | ||
| Q2 24 | 3.44× | 1.13× | ||
| Q1 24 | 1.52× | 2.13× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
PGNY
| Fertility Benefit Services | $208.6M | 66% |
| Pharmacy Benefit Services | $109.8M | 34% |
ROCK
| Transferred At Point In Time | $183.5M | 82% |
| Infrastructure | $22.5M | 10% |
| Other | $18.9M | 8% |
